The largest database of trusted experimental protocols

27 protocols using sodium dl lactate

1

Cardiomyocyte Maturation and Selection

Check if the same lab product or an alternative is used in the 5 most similar protocols
To select and maturate cardiomyocytes, the differentiated cells were cultured for 10 days under one of two conditions: RPMI1640 without glucose (Life Technologies, U.S.A) supplemented with 4 mM sodium DL-lactate (Sigma-Aldrich, U.S.A) and B27-insulin (GIBCO, U.S.A); or RPMI1640 without glucose (Life Technologies, U.S.A) supplemented with 5 mM sodium DL-lactate (Sigma-Aldrich, U.S.A), 500 µg/mL human albumin (Sigma-Aldrich, U.S.A), and 211 µg/mL L-ascorbic acid (Sigma-Aldrich, U.S.A). The medium was replaced every other day.
+ Open protocol
+ Expand
2

Caco-2 Cell Viability Assay for Sodium Lactate

Check if the same lab product or an alternative is used in the 5 most similar protocols
Caco-2 cells (ATCC #HTB-37) were maintained and cultured in Minimum Essential Medium (MEM) media supplemented with 20% fetal bovine serum, 1% of penicillin-streptomycin, 1× non-essential amino acid solution, and 10 mM of sodium pyruvate at 37 °C and 5% CO2.
After subculturing for 24 h, Caco-2 cells were cultured for an additional 24 h prior to treatment with different concentrations (0, 0.78, 3.12, 12.5, 50, 200 mM) of sodium DL-lactate (Sigma-Aldrich). The cell viability was determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay as previously described [88 (link)].
+ Open protocol
+ Expand
3

Evaluating Chemical Compounds for Biological Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
VOR, and NaB and puromycin were purchased from Cayman Chemical (Ann Arbor, MI, USA) and Wako Pure Chemical (Osaka, Japan), respectively. BML-210, GI254023X, sodium DL-lactate (NaL), and BMS-303141 were purchased from Sigma-Aldrich (St. Louis, MO, USA). BEL, ENT, MOC, PNB, and RES were purchased from Selleck Chemicals (Houston, TX, USA), and ROM was purchased from Abcam (Cambridge, United Kingdom). Antibodies to histone H3 and acetyl-histone H3 were purchased from Cell Signaling Technology (Danvers, MA, USA). IL-15 and Cell Counting Kit-8 were purchased from R&D Systems (Minneapolis, MN, USA) and Dojindo (Kumamoto, Japan), respectively. Huh7 and HepG2 cells, as well as PLC/PRF/5 and the NK cell line NK92MI were obtained from American Type Culture Collection (Manassas, VA, USA), and were cultured according to the supplier’s protocols. The cell lines were authenticated by the short tandem repeat method (Bex, Tokyo, Japan) in January 2016. PXB cells were purchased from Phoenix Bio (Hiroshima, Japan).
+ Open protocol
+ Expand
4

Cardiomyocyte Differentiation from hESCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The hESC lines (NKX2.5eGFP/w HES3, H1 and H9-GCaMP6f) with passages 55-65 were routinely maintained and differentiated as described previously 22 (link), 23 (link). In brief, the hESCs were cultured on feeder-free Matrigel (356231, Corning, USA) in E8 medium (A1517001, Thermo Fisher, USA). Before cardiomyocyte differentiation, the hESCs were passaged every 4 days at 80% confluence using 0.5 mM EDTA and re-plated at a density of 2 × 104 cells/cm2. To initiate cardiomyocyte differentiation, the medium was changed with CDM3 (chemically defined medium, three components) containing 5 μM CHIR99021 (C-6556, LC Laboratories, USA) for 48 hours (day 0-2). After a 2-day culture in CDM3, the medium was changed with CDM3 containing 5 μM IWR-1 (I0161, Sigma, USA) for 48 hours (day 4-6). The subsequent culture was in CDM3. The medium was changed every day. Spontaneous beating was commonly observed on day 10. For cardiomyocyte purification, the cells were re-plated on gelatin-coated dishes in RPMI 1640 lacking of glucose and containing 5 mM sodium DL-lactate (L4263, Sigma, USA) from day 11 to day 15 of differentiation. RA (R2625, Sigma, USA) was dissolved in DMSO and added to the CDM3 at the indicated times for cardiomyocyte differentiation and maturation. The final concentration of RA was 1 μM, and the final concentration of DMSO was 0.05% in both groups.
+ Open protocol
+ Expand
5

Efficient Cardiomyocyte Differentiation and Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
ESCs were split and cultured as described above. When cells reached ~ 90% confluence, cardiomyocyte differentiation was initiated by changing the culture medium to differentiation medium CDM3 [20 (link)]. During cardiomyocyte differentiation, cells were treated with 5 μM of the glycogen synthase kinase 3-β inhibitor CHIR99021 (Sigma, USA) on days 0–2 and 2 μM of the Wnt pathway inhibitor Wnt-C59 (Selleck Chemicals, USA) on days 4–6. The medium was changed daily, and spontaneous beating was noted from day 9. For cardiomyocyte purification, the cells were replated and cultured in CDM3L medium, which consisted of glucose-free RPMI 1640 (Thermo Fisher, USA) and 5 mM sodium dl-lactate (Sigma, USA). Cardiomyocytes were then split at 1:4 with 0.25% trypsin (Sigma, USA) containing 0.1 mM EDTA and seeded on 0.1% gelatin-coated dishes in CDM3.
+ Open protocol
+ Expand
6

Cardiac Differentiation of hiPSC

Check if the same lab product or an alternative is used in the 5 most similar protocols
CDM3 hiPSC-CM differentiation was performed with minor modifications as detailed below64 (link),65 (link). All hiPSC lines were differentiated with CDM3 media consisting of RPMI 1640 (11875119, Gibco), 500 µg/mL recombinant human albumin (Sigma-Aldrich, A0237 or Sciencell, OsrHSA), and 213 µg/mL l-ascorbic acid 2-phosphate sesquimagnesium (Sigma-Aldrich, A8960-5G) until day 10. ERRγ KO and its control hiPSC-CMs were maintained with glucose-deficient CDM3 with sodium DL-lactate (Sigma-Aldrich, L4263-100ML) supplementation for 5 days. WTC11 hiPSC-CMs were enriched with glucose-deficient media for 2 days. ERRα/γ KO and control hiPSC-CMs were maintained until day 22 with CDM3 media. We confirmed the cardiac differentiation efficiency in both lines was similar, which was more that 90%10 (link). The purified cardiomyocytes were replated on matrigel-coated plates in 10% FBS supplemented with RPMI 1640 media (Thermo Fisher Scientific, 11875119) and 5 μM Y27632 (Selleck Chemical LLC, S104910MG). Two days after replating, the ERRγ ΚΟ and its control cardiomyocytes were maintained with the glucose-deficient media for an additional 5 days. siRNA transfection was conducted with WTC11 hiPSC-CMs 2 days after replating as described in siRNA transfection section. Adenoviral infection was performed after the 2nd purification with CDM3 media supplemented with 5% FBS.
+ Open protocol
+ Expand
7

Cardiomyocyte Differentiation and Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
A chemically defined molecular-based method was used for CM differentiation (Burridge et al., 2014 (link)). Spontaneous contracting could be observed 7–8 days after differentiation. Then, the CMs were purified by using a metabolic-selection method using the purification medium composed of RPMI 1640 without glucose, 213 μg/mL of l-ascorbic acid 2-phosphate, 500 μg/mL of Oryza sativa-derived recombinant human albumin, and 5 mM of sodium dl-lactate (Sigma, USA).
+ Open protocol
+ Expand
8

Super-resolution Imaging of Native AMPARs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cy3B-STORM was done following the procedure described on Joshua et al (Vaughan et al., 2012 (link)). We labeled neurons with Cy3B-SA (2 μM) following the procedure of sQD labeling. We then fixed the cells with a solution of 4% PFA and 0.1% Glutaraldehyde in HBSS for 10 min. Wash with three tines PBS. Treat the sample with 10 mM of NaBH4 in PBS freshly prepared for 10 min. Wash with PBS. Before imaging, we add imaging buffer consisting of 5 μL of PCD, 20 μL of PCA, 4 μL of Trolox in 471 μL of T-100 (100 mM Tris at pH 8.0). Images were acquired at 10 Hz using 405 nm laser at low power to do activation and 561 nm laser to excite fluorescence.
In order to image native AMPARs, we labeled AMPARs using Anti-GluA2-Alexa647 after fixation. For STORM imaging, we added imaging buffer consisting of 5 mM MEA (Sigma: 30070, St. Louis, MO) solution (~pH 8.0) and additionally added 40 mM Sodium D/L-lactate (Sigma: 71720, St. Louis, MO) and EC-Oxyrase (Sigma: SAE0010, St. Louis, MO) in PBS in order to improve the photo-stability.
+ Open protocol
+ Expand
9

Purification of Cardiomyocyte Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
We purified our cultures by performing a DL-Lactate supplementation. Briefly, at Day 12-15, the medium was changed to RPMI without glucose (Life Technologies, #11879020) containing 5 mM sodium DL-Lactate (Sigma, #4263), 213 µg/mL L-ascorbic acid (Sigma, #A4403) and 500µg/mL human albumin (Sigma, #A9731). Medium was changed every 2 days and after 4 days of DL-Lactate supplementation, the beating cardiomyocytes were thereafter maintained in RPMI+B27 supplement or RPMI+10% FBS. Hence, we were able to obtain highly pure cardiomyocyte cultures, with more than 90% cardiomyocytes at day 20.
+ Open protocol
+ Expand
10

Fungal Growth Profiles on Carbon Sources

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate growth in the presence of different carbon sources SC5314 and the eed1Δ/Δ mutant were diluted to OD600 of 0.1 in YPD medium with 2 or 0.1% glucose or in SD minimal medium (0.67% yeast nitrogen base; BD Biosciences) in the presence of 2% glucose, 0.1% glucose, 2% N-acetyl-glucosamine (GlcNAc; Sigma–Aldrich), 2% sodium-DL-lactate (Sigma Aldrich), 2% potassium acetate (Merck), 2% citric acid monohydrate (Roth) or 2% casamino acids (BD Biosciences). For testing of proteolytic activity, C. albicans strains were grown in SD medium overnight, washed twice with PBS and OD600 was set to 0.1 in YCB-BSA (1.17% Yeast Carbon Base (BD Biosciences), 1% glucose, 0.5% BSA (Serva)), pH 4.0. For growth in kidney homogenates, kidneys of uninfected mice were removed aseptically, homogenized and diluted to 25 mg/ml in DPBS and filtered through 70 µm and 40 µm cell strainers before filter sterilization. Growth was recorded by measuring OD600 in a microplate reader at 37 °C. Measurements were performed in 30 min intervals over a course of 60 h. Blank values were subtracted from all measurements.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!